Papalocal
Loading…
Papalocal · People
Uğur Şahin
Picture: BioNTech, via Wikimedia Commons · CC BY-SA 4.0

Uğur Şahin

German oncologist of Turkish descent, immunologist, developer of COVID-19 vaccines (born 1965)
1965 – present · oncologist · Germany
43 facts · 1 confirmed
This profile was compiled from public sources, and may be incomplete or out of date. Are you Uğur Şahin? Sign in to claim your People Profile — edit it, add your input, or request changes/removal.

Uğur Şahin is a German oncologist of Turkish descent, immunologist, developer of COVID-19 vaccines. Born September 19, 1965, in İskenderun. Positions held include university teacher (2006–) and chief executive officer (2008–). Educated at University of Cologne and Erich Kastner Gymnasium. Awards include Georges Köhler Prize, Mustafa Prize and German Cancer Award.

Facts

43 facts · 1 confirmed by two sources · 26 cited · 16 from one source

Born
September 19, 1965 Confirmed
Born in
İskenderun Cited
Citizen of
Germany Cited
Turkey Cited
Occupation
oncologist Cited
physician Cited
academic Cited
immunologist Cited
Worked for
Field
vaccine development One source
medicine Cited
oncology Cited
immunology Cited
vaccine Cited
COVID-19 Cited
Spouse
Özlem Türeci Cited
Website
https://biontech.de/de/our-dna/fuehrungsteam One source

Where this comes from

Papalocal keeps its own record. It started from these sources; what each one said is kept here as it was copied, so a change on their side never changes this page by itself. Tap one to read its version.

What Wikidata says · copied November 16, 2026 · revision 2570413474
Described as
German oncologist of Turkish descent, immunologist, developer of COVID-19 vaccines (born 1965)
Other names
Ugur Sahin, Şahin, Sahin
Born
September 19, 1965 · 2 references
Born in
İskenderun · 2 references
Citizen of
Germany · 1 reference; Turkey · 4 references
Occupation
oncologist · 1 reference; university teacher · 2 references; entrepreneur · 1 reference; physician · 2 references; chief executive officer; researcher · 1 reference; academic · 1 reference; immunologist · 1 reference
Positions held
university teacher (2006–); chief executive officer (2008–)
Worked for
Johannes Gutenberg University Mainz; BioNTech
Education
University of Cologne (1984–1992); Erich Kastner Gymnasium; Saarland University (1992–1994)
Member of
German Academy of Sciences Leopoldina · 1 reference
Awards
Georges Köhler Prize (2005); Mustafa Prize (2019) · 1 reference; German Cancer Award (2019); Financial Times Person of the Year (2020); Axel Springer Award (2021) · 1 reference; Knight Commander's Cross of the Order of Merit of the Federal Republic of Germany (2021); Princess of Asturias Award for Technical and Scientific Research (2021) · 1 reference; honorary doctor of University of Cologne (2021) · 1 reference; Paul Ehrlich and Ludwig Darmstaedter Prize (2022) · 1 reference; EMBO Membership; University Teacher of the Year (2022); Louis-Jeantet Prize for Medicine (2022) · 1 reference; Warren Alpert Foundation Prize (2022) · 1 reference; William B. Coley Award (2021) · 1 reference; honorary doctor of the University of Antwerp (2022) · 1 reference
Field
vaccine development; medicine · 1 reference; oncology · 1 reference; immunology · 1 reference; vaccine · 1 reference; COVID-19 · 1 reference
Spouse
Özlem Türeci · 2 references
Website
https://biontech.de/de/our-dna/fuehrungsteam · 1 reference
Wikipedias with a page
36

Wikidata item Q2505089 (wikidata.org/wiki/Q2505089), public domain (CC0). Copied November 16, 2026.

What Wikipedia says · copied November 16, 2026 · revision 1380656771

Uğur Şahin (Turkish: [uˈuɾ ʃaː.hin]; born 19 September 1965) is a German medical researcher, entrepreneur, and businessman. He is the co-founder and CEO of BioNTech, which developed the world’s first mRNA-based vaccine against COVID-19. He also serves as chairman of the scientific management board of the Helmholtz Institute for Translational Oncology (HI-TRON), a Mainz-based cutting-edge biopharmaceutical research laboratory he co-founded in 2018. He is co-inventor of more than 500 filed patents applications and patents. His main fields of research are cancer research and immunology.
Şahin's family, originally from Turkey, moved to Germany when he was four years old. He grew up in Cologne and studied medicine at the University of Cologne, completing a doctoral thesis there in cancer immunotherapy. He initially remained in academia, in patient care as an oncohematology physician and conducting research at university hospitals in Saarland and Zürich. He founded a research group at the University of Mainz in 2000 and became a professor of experimental oncology in 2006.
In 2001, while maintaining his position at the University of Mainz, Şahin began to engage in entrepreneurial activities, co-founding two pharmaceutical companies, in 2001 and 2008, with his partner and spouse Özlem Türeci. The second of these companies, BioNTech, together with Pfizer Inc, developed one of the major vaccines used to fight the COVID-19 pandemic in 2020. As a result of the company's increase in value, Şahin and Türeci became the first Germans with Turkish roots among Germany's 100 wealthiest people.

Born, in its opening lines
September 19, 1965

From the Wikipedia article “Uğur Şahin” (en.wikipedia.org/wiki/Uğur_Şahin), by its contributors, under CC BY-SA 4.0 (creativecommons.org/licenses/by-sa/4.0/). Copied November 16, 2026; not changed.

Confirmed Two sources agree. Cited One source, and it names where it got it. One source One source, without a reference of its own. Sources disagree The sources disagree. We show the best-supported value and keep theirs below.

Papalocal’s own record, started from Wikidata and Wikipedia.Report / request a correction